| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 07/31/2007 | CA2333603C New dipeptidyl peptidase iv effectors |
| 07/31/2007 | CA2227688C Methods and compositions for inhibition of viral replication |
| 07/26/2007 | WO2007084857A2 Methods and compositions for treating cell proliferative disorders |
| 07/26/2007 | WO2007084670A2 Specific therapy using integrin ligands for treating cancer |
| 07/26/2007 | WO2007083611A1 Spontaneous pulmonary hypertension model animal, method for production of the model animal, pharmaceutical composition for pulmonary hypertension, and therapeutic method for pulmonary hypertension |
| 07/26/2007 | WO2007083522A1 Gel-forming composition for medical use, devices for the application of the composition, and drug release controlling carrier |
| 07/26/2007 | WO2007082935A1 Use of a combination of morphine and at least one opiate antagonist for treatment of opiate dependency and for prevention of non-oral opiate abuse in opiate addicts |
| 07/26/2007 | WO2007082780A1 Use of alkanedicarboxylic acids and retinoids for treatment of rosacea and other inflammatory skin diseases |
| 07/26/2007 | WO2007082381A1 Compositions containing (s)-bethanechol and their use in the treatment of insulin resistance, type 2 diabetes, glucose intolerance and related disorders |
| 07/26/2007 | WO2007064945A3 Cancer therapies and pharmaceutical compositions used therein |
| 07/26/2007 | WO2007046113A3 Novel pharmaceutical composition comprising alkaloid and process thereof |
| 07/26/2007 | WO2007037850A3 Enhanced delivery of cells |
| 07/26/2007 | WO2005019417A3 Bacterial strains, compositions including same and probiotic use thereof |
| 07/26/2007 | US20070174926 Sperm factor oscillogenin |
| 07/26/2007 | US20070174924 Transgenic mice containing TRP gene disruptions |
| 07/26/2007 | US20070174922 Nucleic acid encoding novel type-1 cytokine receptor glm-r |
| 07/26/2007 | US20070173913 Methods and devices for epithelial protection during photodynamic therapy |
| 07/26/2007 | US20070173784 Methods for enhancing fluid flow through an obstructed vascular site, and systems and kits for use in practicing the same |
| 07/26/2007 | US20070173548 Malonamic acids and derivatives thereof as thyroid receptor ligands |
| 07/26/2007 | US20070173524 N-[2-(Indol-3-yl)ethyl]-S-methyl-dithiocarbamate; N-[2-(benzo[b]thiophen-3-yl)ethyl]-S-methyl-dithiocarbamate; N-[2-(indol-3-yl)ethyl]-S[(naphth-2-yl)methyl]-dithiocarbamate; anticarcinogenic agents; free of brassinin |
| 07/26/2007 | US20070173478 Compositions for the enhanced treatment of depression |
| 07/26/2007 | US20070173454 Administering an agent that decreases or regulates the blood level, production, function or activity of gonadotropins-leutinizing hormone, follicle stimulating hormone, activin or follistatin; parkinson's disease |
| 07/26/2007 | US20070173436 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 07/26/2007 | US20070172532 Complex Mixtures Exhibiting Selective Inhibition of Cyclooxygenase-2 |
| 07/26/2007 | US20070172474 Dairy components effective for fat loss |
| 07/26/2007 | US20070172469 Methods For Inhibiting Viral Replication In Vivo |
| 07/26/2007 | US20070172467 for a disorder of a subject's heart involving loss of cardiomyocytes by administering an amount of an agent effective to cause cardiomyocyte proliferation within the subject's heart; Vitamin D3 Up-Regulated Protein-1; peroxiredoxin |
| 07/26/2007 | US20070172444 Hair tonics and method of screening the same |
| 07/26/2007 | DE10303229B4 Ambroxol und Inhibitoren des Angiotensin Converting-Enzyms (ACE) umfassende Arzneimittel Arzneimittel-Zubereitung und ihre Verwendung zur Behandlung von neurodegenerativen Erkrankungen Ambroxol and inhibitors of the angiotensin converting enzyme (ACE) pharmaceutical compositions comprising drug preparation and their use for the treatment of neurodegenerative diseases |
| 07/26/2007 | DE102006004804A1 Verwendung von Alkandicarbonsäuren und Retinoiden zur Behandlung entzündlicher Hauterkrankungen Use of alkanedicarboxylic and retinoids for the treatment of inflammatory skin diseases |
| 07/26/2007 | DE102005058639A1 Behandlung von Trichodynie und anschwellender Arteria temporalis superficialis Treatment of Trichodynia and intumescent Superficial temporal artery |
| 07/26/2007 | CA2637635A1 Gel-forming composition for medical use, administration device for the composition, and drug release controlling carrier |
| 07/26/2007 | CA2637458A1 Use of a combination of morphine and at least one opiate antagonist to treat opiate dependency and prevent non-oral opiate abuse among opiate addicts |
| 07/26/2007 | CA2637387A1 Specific therapy using integrin ligands for treating cancer |
| 07/26/2007 | CA2633774A1 Use of alkanedicarboxylic acids and retinoids for treatment of rosacea and other inflammatory skin diseases |
| 07/25/2007 | EP1811025A1 Mutated amyloid protein |
| 07/25/2007 | EP1811018A1 Brain disposition marrow progenitor |
| 07/25/2007 | EP1810969A1 Aryloxy-substituted benzimidazole derivatives |
| 07/25/2007 | EP1810715A2 Combination comprising an agent decreasing VEGF activity and an agent decreasing EGF activity |
| 07/25/2007 | EP1810693A2 Combinations of sterol absorption inhibitor(s) with blood modifier(s) for treating vascular conditions |
| 07/25/2007 | EP1810692A1 Remedies/preventives for chronic skin disease |
| 07/25/2007 | EP1810691A2 Immunotherapy for reversing immune suppression |
| 07/25/2007 | EP1810689A1 Preventive and/or therapeutic agent for diabetes |
| 07/25/2007 | EP1810680A2 Compositions and methods for use in targeting vascular destruction |
| 07/25/2007 | EP1810678A1 Use of morphine and naloxone for drug substitution |
| 07/25/2007 | EP1809742A2 Methods for treating conditions associated with the accumulation of excess extracellular matrix |
| 07/25/2007 | EP1809734A2 Disease treatment via developing non-syngeneic graft transplantation |
| 07/25/2007 | EP1809304A2 Methods of entrapping, inactivating, and removing viral infections by the administration of respiratory tract compositions |
| 07/25/2007 | EP1809286A2 Method for treatment of movement disorders |
| 07/25/2007 | EP1809285A1 Combinations of nicotinic acetylcholine alpha 7 receptor agonists |
| 07/25/2007 | EP1809278A2 Combinations of pkc activators and pkc inhibitors for for alzheimer's disease treatment and cognitive enhancement |
| 07/25/2007 | EP1809271A2 (halobenzyloxy) benzylamino-propanamides as sodium and/or calcium channel selective modulators |
| 07/25/2007 | EP1427383B1 Compositions and methods relating to prevention of chemotherapy-induced alopecia |
| 07/25/2007 | EP1397364B1 Novel pyrrole derivatives as pharmaceutical agents |
| 07/25/2007 | EP1383502A4 Compounds and methods for the treatment of urogenital disorders |
| 07/25/2007 | EP1355660B1 Composition and kit for use in the treatment of tumors |
| 07/25/2007 | EP1335711B1 Transdermal device |
| 07/25/2007 | EP1325000B1 A thiazolidinedione derivative and its use as antidiabetic |
| 07/25/2007 | EP1322289B1 Spray drying process of compositions containing fenofibrate |
| 07/25/2007 | EP1319184B1 Use of antibodies against specific mhc-peptide complexes |
| 07/25/2007 | EP1299100B1 Method of treating hot flashes, using tachykinin receptor antagonist |
| 07/25/2007 | EP1286664B1 Combination of low dose estrogen and immunotherapeutic agent for treating immune diseases |
| 07/25/2007 | EP1212621B1 Screening for agents modulating tgf-beta cell signalling |
| 07/25/2007 | EP1175508B1 Optical probes and assays for measuring protein phosphorylation |
| 07/25/2007 | EP1143933B1 Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules |
| 07/25/2007 | EP0820281B1 A pharmaceutical composition containing n-chlorophenylcarbamates and n-chlorophenylthiocarbamates for inhibiting the growth of viruses |
| 07/25/2007 | CN1328285C Inhibitor of stem cell proliferation and uses thereof |
| 07/25/2007 | CN1328279C Viral inhibitors |
| 07/25/2007 | CN1328260C Beta crystalline form of perindopril tert-butylamine salt, preparation method and pharmaceutical compositions containing same |
| 07/25/2007 | CN1328259C Alpha crystalline form of perindopril tert-butyllamine salt |
| 07/25/2007 | CN1328258C Gamma crystalline form of perindopril tert-butylamine salt, preparation method and pharmaceutical compositions containing same |
| 07/25/2007 | CN1327898C Anti-inflammatory fatty alcohols and fatty acid esters useful as antigen carriers |
| 07/25/2007 | CN1327844C Combination therapy comprising a bisphosphonate and a HMG-COA reductase inhibitor |
| 07/25/2007 | CN1327827C Coated granules based on angiotensin-converting enzyme inhibitor |
| 07/25/2007 | CN1327826C Treatment of vascular thrombosis and restenosis with inhaled nitric oxide |
| 07/25/2007 | CN1327825C Solid oral compositions |
| 07/25/2007 | CN101005855A Methods of treating CCR2 mediated diseases or disorders |
| 07/25/2007 | CN101005854A Method for augmenting B cell depletion |
| 07/25/2007 | CN101002973A Catheter with polymeric coating |
| 07/25/2007 | CN101002947A Target medicine used for treating bacteriosis, and its preparing method |
| 07/25/2007 | CN101002941A Anticarcinogen composition carried with platinum compound and vasoinhibitor |
| 07/25/2007 | CN101002940A Medicine composition for treating polycystic renal disease |
| 07/25/2007 | CN101002939A Medicine composition for treating diseases relating to gastric acid |
| 07/25/2007 | CN101002938A Oral formulation containing itraconazole and methods for manufacturing and using the same |
| 07/25/2007 | CN101002758A Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes |
| 07/25/2007 | CN101002730A Compounding anticarcinogen containing neovascular-inhibitor |
| 07/25/2007 | CN101002729A Slow released anticarcinogen containing vasoinhibitor |
| 07/25/2007 | CA2575395A1 Dispenser for dispensing three or more actives |
| 07/24/2007 | US7247766 Double transgenic mice overexressing human beta secretase and human APP-London |
| 07/24/2007 | US7247610 Suppression tumor growth |
| 07/24/2007 | US7247502 Nicotine hapten that is nicotine in which the pyrrolidine ring is substituted by an omega-carboxy-, -amino-, -formyl- or -mercapto-alkyl group; useful in formulating vaccines for active immunization |
| 07/24/2007 | US7247446 PRO34128 nucleic acids |
| 07/24/2007 | US7247444 Use of interleukin-19 to treat cervical cancer |
| 07/24/2007 | US7247301 Human monoclonal antibodies to epidermal growth factor receptor (EGFR) |
| 07/24/2007 | CA2290505C Automated robotic system and method for rapidly screening and identifying useful chemicals in liquid samples |
| 07/24/2007 | CA2230350C Combination preparation for use in dementia |
| 07/24/2007 | CA2172777C Use of a cgrp antagonist for the treatment of neurogenic skin redness; composition thus produced |
| 07/19/2007 | WO2007081061A1 Therapeutic agent for neurogenic pain |
| 07/19/2007 | WO2007081060A1 Therapeutic agent for neuropathic pain |
| 07/19/2007 | WO2007080977A1 Preventive or therapeutic agent and method for immune disease |